Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease
Results of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.
The Canadian research team was the first to use gene therapy in 2017 to treat patients with Fabry disease, a rare, chronic illness that can damage major organs and shorten lives. They report their findings today in the journal
Nature Communications. Being one of the first people in the world to receive this treatment, and seeing how much better I felt afterward, it definitely gives me hope that this can help many other Fabry patients and potentially those with other single gene mutation disorders, says Ryan Deveau, one of the participating patients in Dartmouth, Nova Scotia. Now that I don t have to get the replacement therapy every two weeks, I have more time to spend with my family.
Gene therapy show promise in taming rare disease: U of C scientist
calgaryherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from calgaryherald.com Daily Mail and Mail on Sunday newspapers.
A Canadian success story: world-first to treat Fabry disease with gene therapy
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.